Featured Research

from universities, journals, and other organizations

Hopkins Researchers Find Tourette Drug Has Unexpeded Effect

Date:
March 19, 2001
Source:
Johns Hopkins Medical Institutions
Summary:
A new study by Johns Hopkins Children's Center neurologists suggests that baclofen, a drug long thought to be effective in reducing the vocal and motor tics associated with Tourette syndrome, improves a patient's overall sense of well-being but does not significantly reduce tics.

A new study by Johns Hopkins Children's Center neurologists suggests that baclofen, a drug long thought to be effective in reducing the vocal and motor tics associated with Tourette syndrome, improves a patient's overall sense of well-being but does not significantly reduce tics.

Related Articles


"One of our conclusions is that baclofen helps as a treatment for Tourette syndrome, but it appears to improve something other than tics," says pediatric neurologist Harvey Singer, M.D., the report's lead author. "We originally thought baclofen would diminish patients' vocal and muscular tics but found, instead, that it's more useful in making patients feel less impaired by their tics."

In the first double-blind study of baclofen in patients with Tourette syndrome (TS), the research team scored the severity of TS symptoms of nine children between the ages of 8 and 14 years by using two standard indices, the Clinical Global Impression and Yale Global Tic Severity scales. Their report, which appears in this month's Neurology, reveals that patients in the study said they were less "impaired" while using the drug, even though phonic and motor tics did not significantly diminish in frequency.

While baclofen caused no major side effects among children in the placebo-controlled, crossover study, Singer says the drug may not be the most effective medication for suppressing tics in children with TS.

"Learning which kinds of drugs suppress tics the best may enable us to develop more effective treatments in the future," Singer says. "Testing medications in a rigorous setting represents the first step in identifying better therapies for TS."

The number of TS drugs doctors have to choose from may be quite large, since the underlying mechanism for tics may involve several brain chemicals, or neurotransmitters. As a "tier-1" drug, baclofen does not cause severe or long-term side effects, but its effect in reducing tics may be less potent than other medications in this category. Tier-2 medications have a greater effectiveness in suppressing tics but have a large risk for causing long-term side effects. Singer and other neurologists are actively searching for new tier-1 drugs that improve tic symptoms without causing severe side effects.

Baclofen, a neurotransmitter mimic, alters brain activity by binding to one of the GABA neurotransmitter receptors which, in turn, suppresses the release of other brain chemicals. Baclofen is also used to treat motor abnormalities associated with cerebral palsy, spasticity and Huntington's disease.

John Wendlandt, B.S., Madeline Krieger, R.N., and Joseph Giuliano, R.N., of the Children's Center Division of Pediatric Neurology contributed to the report. It was supported in part by the Friends of Tourette Syndrome Research.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Hopkins Researchers Find Tourette Drug Has Unexpeded Effect." ScienceDaily. ScienceDaily, 19 March 2001. <www.sciencedaily.com/releases/2001/03/010313074530.htm>.
Johns Hopkins Medical Institutions. (2001, March 19). Hopkins Researchers Find Tourette Drug Has Unexpeded Effect. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2001/03/010313074530.htm
Johns Hopkins Medical Institutions. "Hopkins Researchers Find Tourette Drug Has Unexpeded Effect." ScienceDaily. www.sciencedaily.com/releases/2001/03/010313074530.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins